Introduction

Substance use is already embedded in employer healthcare spend even when it does not appear clearly in claims data. It contributes to inpatient admissions, emergency room visits, chronic disease complications, and rising pharmacy costs. At the same time, it quietly affects how employees show up to work, how often they are absent, and whether they remain in the workforce at all.

According to the Centers for Disease Control and Prevention (CDC), untreated substance use costs employers and payers more than $15,000 per affected individual each year, not including productivity losses, absenteeism, or turnover
Despite this impact, substance use frequently goes undiagnosed or undisclosed. The Substance Abuse and Mental Health Services Administration (SAMHSA) reports that fewer than 10% of people with a substance use disorder receive treatment in a given year.

At DevotedDOc, we work with employers and organizations to address substance use as what it is: a medical and workforce issue that requires early, evidence-based intervention not delayed, crisis-driven responses.

Understanding the True Cost of Substance Use to Employers

Substance use affects far more than medical claims. Employees struggling with substance use disorder miss an average of five weeks of work per year and take significantly more unscheduled leave than their peers. Even when employees remain on the job, presenteeism and reduced performance are common.

The National Institute on Drug Abuse (NIDA) emphasizes that substance use disorders are chronic medical conditions that affect physical health, mental health, and functional capacity

When substance use is not addressed early, employers often see costs emerge later in more expensive forms: hospitalizations, ER utilization, disability claims, and employee replacement costs.

Why Substance Use Is Often Invisible in Data

One of the biggest challenges employers face is that substance use does not always show up clearly in reporting. Claims data may list diagnoses such as gastrointestinal issues, cardiovascular disease, psychiatric conditions, or injuries without identifying substance use as the underlying contributor.

SAMHSA notes that stigma, privacy concerns, and fear of job consequences prevent many individuals from disclosing substance use or seeking care

As a result, substance use remains a “hidden” cost driver, even as healthcare budgets continue to tighten.

Rising Healthcare Costs and the Pressure on Employers

Employer-sponsored healthcare costs are rising at their fastest pace in over a decade. Benefits leaders are under increasing pressure to reduce spend while maintaining access and outcomes.

The U.S. Department of Labor highlights that mental health and substance use treatment are essential benefits under parity laws, yet many plans struggle to deliver effective care models
 

This environment has accelerated interest in care models that can demonstrate both clinical impact and financial return particularly in behavioral health.

The Shift Toward Modern Substance Use Management Models

Traditional substance use treatment models often rely on referrals, long wait times, geographic proximity, and in-person care. These barriers contribute to delayed treatment and disengagement.

Federal agencies increasingly recognize virtual and outpatient care as critical tools for expanding access. The U.S. Department of Health and Human Services notes that telehealth can reduce access gaps, especially for behavioral health services

Modern substance use management focuses on:

• Early identification
  
• Confidential access
  
• Evidence-based outpatient care
  
• Continuous engagement
  
• Measurable outcomes
  

This is the foundation of DevotedDOc’s care model.

Evidence That Early, Digital-First Care Reduces Costs

Recent peer-reviewed research evaluating digital substance use care shows that when individuals receive support earlier often before a formal diagnosis medical costs decline significantly.

Participants in digital substance use programs experienced:

• Fewer inpatient admissions
  
• Reduced emergency and urgent care visits
  
• Lower overall medical spend across multiple categories
  

NIDA has consistently found that effective treatment reduces healthcare utilization and improves long-term stability

Importantly, many individuals reached by digital care models had no prior documented substance use diagnosis, highlighting the value of early access.

Why Early Engagement Matters

Engagement is one of the strongest predictors of both clinical and financial outcomes. Individuals who consistently attend appointments and use support tools experience better health outcomes and lower medical costs.

SAMHSA emphasizes that timely, accessible care improves retention and reduces escalation to crisis-level services

Digital-first models reduce common barriers to care, including:

• Cost concerns
  
• Lack of provider availability
  
• Fear of workplace stigma
  
• Privacy worries
  

By removing these obstacles, employers can manage risk earlier when intervention is more effective and less expensive.

The Broader Health Impact of Treating Substance Use

Addressing substance use does not only reduce costs tied directly to addiction-related claims. It also impacts broader health categories.

The CDC identifies substance use as a contributing factor in chronic conditions such as heart disease, cancer, gastrointestinal disorders, and mental health conditions

When substance use is treated effectively, reductions often appear in:

• Psychiatric care utilization
  
• Gastrointestinal treatment
  
• Cardiovascular services
  
• Pulmonary and musculoskeletal claims
  

This reinforces the role of substance use management as a whole-person health strategy, not a siloed benefit.

Why Pricing Models Matter to Employers

Not all behavioral health programs are structured the same way. Some virtual programs charge per-member-per-month fees regardless of engagement, which can increase costs without guaranteeing impact.

Benefits leaders are increasingly scrutinizing whether investments are tied to actual participation and outcomes. In a constrained budget environment, how care is priced matters as much as whether care exists.

Federal health policy discussions increasingly emphasize value-based approaches that align cost with results.

DevotedDOc’s model focuses on meaningful engagement, physician-led care, and measurable outcomes rather than flat, utilization-agnostic pricing.

What This Means for Employer Benefits Strategy

For many organizations, substance use remains a line item without a defined strategy behind it despite being one of the most expensive and overlooked drivers of healthcare spend.

The data is clear:

• Substance use increases medical costs
  
• It affects attendance, productivity, and retention
  
• Most affected individuals never receive care
  
• Early intervention reduces both health and financial risk
  

The opportunity is not just to treat substance use, but to manage it intentionally, consistently, and at scale.

How DevotedDOc Supports Employers and Employees

DevotedDOc delivers physician-led, telehealth-based substance use management designed for working adults and employer populations. Our approach emphasizes:

• Early access to care
  
• Confidential, stigma-free treatment
  
• Evidence-based clinical models
  
• Ongoing engagement and support
  
• Alignment with federal best practices
  

Our care model supports individuals with alcohol use disorder, opioid use disorder (including MAT), and co-occurring mental health conditions helping employers address risk before it escalates.

Conclusion

Substance use is already affecting healthcare budgets, workforce stability, and organizational performance whether it is visible or not. With the majority of affected individuals untreated, the cost of inaction continues to grow.

The question for employers is no longer whether substance use should be addressed, but how intentionally and effectively it is managed.

Evidence shows that when care reaches people earlier, removes access barriers, and is tied to real engagement, both health outcomes and financial results improve. In an environment where every investment is under review, substance use management deserves a clearer, more strategic role in benefits planning.

DevotedDOc helps organizations move from reactive spending to proactive risk management treating substance use as a medical condition and supporting recovery through accessible, physician-led care.

Frequently Asked Questions